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Abstract Since amyotrophic lateral sclerosis (ALS) can
be accompanied by executive dysfunction, it is hypothe-
sised that ALS patients will have impaired performance on
tests of cognitive inhibition. We predicted that ALS
patients would show patterns of abnormal activation in
extramotor regions when performing tests requiring the
inhibition of prepotent responses (the Stroop effect) and the
inhibition of prior negatively primed responses (the nega-
tive priming effect) when compared to healthy controls.
Functional magnetic resonance imaging was used to mea-
sure activation during a sparse sequence block design
paradigm investigating the Stroop and negative priming
effects in 14 ALS patients and 8 healthy age- and IQ-
matched controls. Behavioural measures of performance
were collected. Both groups’ reaction times (RTs) reflected
the Stroop effect during scanning. The ALS and control
groups did not differ significantly for any of the behav-
ioural measures but did show significant differences in
cerebral activation during both tasks. The ALS group
showed increased activation predominantly in the left
middle temporal gyrus (BA 20/21), left superior temporal
gyrus (BA 22) and left anterior cingulate gyrus (BA 32).
Neither group’s RT data showed clear evidence of a nega-
tive priming effect. However the ALS group showed
decreased activation, relative to controls, particularly in the
left cingulate gyrus (BA 23/24), left precentral gyrus (BA
4/6) and left medial frontal gyrus (BA 6). Greater cerebral
activation in the ALS group accompanying the perfor-
mance of the Stroop effect and areas of decreased activa-
tion during the negative priming comparison suggest
altered inhibitory processing in ALS, consistent with other
evidence of executive dysfunction in ALS. The current
findings require further exploration in a larger study.
Keywords Amyotrophic lateral sclerosis  fMRI 
Cognitive function  Response inhibition
Introduction
Depending on the criteria used, 35–50% of people with
amyotrophic lateral sclerosis (ALS) may show cognitive
impairment, particularly executive dysfunction (e.g. [1–4])
with milder deficits of memory and language (e.g. [5]). The
most widely reported deficits have been on tests of verbal
fluency where a formal adjustment has been made for
motor or speech impairments (e.g. [6–10]) as well as in
other studies [11–13]. Neuroimaging studies have related
verbal fluency impairment to altered patterns of cerebral
activation [8, 11, 14–16] and to the reduction of white
matter volume in frontotemporal association fibres [17].
Less consideration has been given to the cerebral acti-
vation underlying cognitive function in ALS using other
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cognitive, extramotor paradigms [18], particularly assess-
ing attention. Although on the basis of a meta-analysis it
was concluded that ALS patients do not show attentional
impairments [2], deficits have been reported on tests of
visual attention [19]. The Stroop test, which measures
focused attention and response inhibition, has yielded
contradictory results [11, 20–23]. In the Stroop test [24],
there is an increase in response time when naming the
colour of the ink in which an incongruous colour name is
displayed (e.g. when the participant has to say ‘blue’ in
response to the word ‘RED’ printed in blue ink) in com-
parison to control conditions where the stimulus charac-
teristics do not conflict with each other (e.g. RED printed in
red ink). This is known as the Stroop effect. In a previous
study [6] no difference in the Stroop effect was found when
comparing the performance of 52 ALS patients and healthy
controls. However, a strong trend (p = 0.051) for a
between-group difference was found on a further adapta-
tion of the Stroop test, known as negative priming (NP)
[25]. In the NP task, participants are also required to name
the colour of the ink in which an incongruous colour word
is printed, but the colour of the ink is the same as the colour
word on the previous trial, e.g. RED in blue ink is followed
by GREEN in red ink. Thus the correct response on any
trial is the stimulus that on the previous trial had to be
ignored as a distractor. The task, therefore, requires the
person to inhibit responses on a particular trial and then
make the previously inhibited response on the next trial. In
healthy controls, the NP task produces increased (i.e.
slower) response times compared to the Stroop effect. The
NP task has therefore been interpreted as making greater
demands on active inhibitory cognitive processes [26].
Two theoretical models have been used to account for the
NP effect, the selective inhibition account and the episodic
retrieval model [27]. In our previous study [6], the ALS
group showed shorter response latencies compared to
controls for the NP effect. This was interpreted as sug-
gesting impairment of normal cognitive inhibitory pro-
cesses. In this scenario, less cognitive inhibition of a
stimulus on trial ‘N’ would make this stimulus easier to
respond to on trial ‘N ? 1’ and would lead to a shorter
response time than would a stronger level of cognitive
inhibition on trial ‘N’. In addition, if there is impaired
cognitive inhibition (which in the Stroop task is reflected
by longer response times resulting from poorer inhibition
of the colour word when naming the colour ink is required),
this would ‘help’ the ALS patients in the NP trials and lead
to a reduced NP effect. Elsewhere, patients with frontal
lobe damage have also been reported to show reduced NP
effects [28], which further suggests altered cognitive
inhibitory processes. Other clinical groups thought to
demonstrate reductions in cognitive inhibition have also
shown a reduced NP effect [29, 30].
In healthy controls, fMRI has demonstrated predomi-
nantly the involvement of the cingulate gyrus, the inferior,
superior and medial frontal gyrus and the hippocampal
gyrus during the Stroop test [26, 31, 32]. The inferior,
superior and middle frontal gyrus, superior and middle
temporal as well as inferior parietal lobe and thalamus were
among the regions found to show differential activation
comparing performance during the NP test and the Stroop
test [26]. Since a number of functional neuroimaging
studies and neuropathology investigations have shown
involvement of a selection of these regions in ALS (e.g. [8,
11, 14, 33, 34]), the present study set out to determine, in a
pilot study, whether performance on Stroop and negative
priming paradigms during fMRI scanning would elicit
patterns of abnormal activation in extramotor regions
known to be implicated more generally in cognitive
impairment in ALS [4]. The study also set out to explore
whether the patterns of cerebral activation in patients with
ALS might elucidate the nature of inhibitory process
changes seen in ALS in our previous study [6].
Methods
Participants
Fourteen people with possible, probable or definite ALS
according to the revised El-Escorial criteria [35] were
recruited from the King’s MND Care and Research Centre
in London. None had a clinical diagnosis of dementia.
Individuals with a family history of ALS were excluded, as
were people with very slow/unintelligible speech (which
would make measuring performance on the Stroop/nega-
tive priming test impossible) or forced vital capacity\80%
as hypoventilation may impair cognitive function in ALS
[36, 37]. Eight control participants were recruited from
among friends/spouses of the people with ALS or from
among a departmental participant pool of healthy adults.
Exclusion criteria for both patients and controls included:
(1) not being right-handed; (2) a history of diabetes, stroke,
head injury or loss of consciousness; (3) a history of a
psychiatric or psychological disorder or currently taking
psychotropic medication; (d) colour-blindness. More peo-
ple with ALS than controls were recruited to incorporate
the likely heterogeneity in cognitive ability seen in the
disorder [1–4].
Measures
Symptom severity was measured using the ALS Severity
Scale [38]. This scale, used in other scanning and neuro-
psychology studies by our group (e.g. [6–10, 14]) provides
summary scores of bulbar and spinal function as well as a
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total score. Bulbar and spinal scores each have a maximum
of 20 with higher scores indicating less functional
impairment. Premorbid general intellectual ability was
assessed using the National Adult Reading Test [39].
Anxiety and depression were measured using the Hospital
Anxiety and Depression Scale (HADS) [40]. For each of
the anxiety and depression subscales, scores between 0–7
are considered normal, 8–10 represents a borderline state of
anxiety or depression, and scores above 10 indicate
‘‘caseness’’. Depression scores with and without the item
‘‘I feel as if I am slowed down’’ [6, 8, 14] were calculated.
Age and clinical measures were compared between the
ALS and healthy groups with the Mann-Whitney U test,
while gender was compared with Fisher’s exact test.
The project received ethical approval from the Ethics
Committee at the Institute of Psychiatry, King’s College
London. All participants gave written informed consent
prior to participating in the study, which was performed in
accordance with the ethical standards laid down in the 1964
Declaration of Helsinki.
Neuroimaging paradigm
Control, Stroop and negative priming tasks
Three sets of stimuli were presented to participants in the
MRI scanner. Two sets of stimuli consisted of words
(BLUE, GREEN, RED AND YELLOW) presented in
another one of those colours, as well as control stimuli,
which were strings of between three and six coloured
crosses, presented in the colours above. In the Stroop
condition, the incongruous colour of the ink in which the
word was printed was unrelated to the word presented on
the previous trial. For the NP stimuli, the colour ink was
the same as the colour word on the previous trial (e.g. RED
written in green ink was followed by BLUE written in red
ink). In all conditions the participants were instructed
simply to name the colour of the ink in which the stimuli
were presented. No further information was given about
how the colour ink and nature of the stimulus were related.
Three sets of stimuli were compiled in order to compare
the Stroop versus control conditions, NP versus control
conditions and Stroop versus NP. Within each set, there
were five alternating blocks of trials per condition, with 8
trials per block. For all stimulus classes, participants were
presented with a fixation cross for 1,800 ms, the stimulus
was presented for 100 ms, and there was then a blank
period (interstimulus interval; ISI) of 2.6 s during which
the response was to be made. The response time was
established on the basis of prior pilot work to provide
sufficient response time for the ALS patients. Since the
response to NP trials depends on the previous stimulus, the
first trial was discarded; consequently in the calculation of
results for all conditions the first trial of each block was
discarded.
For each main set of trials (Control vs. Stroop; Control
vs. NP; Stroop vs. NP) two different randomised trial pre-
sentations were generated, and the use of these two orders
was counterbalanced across participants, as was the order in
which the different blocks was presented. Voice-activated
hardware recorded the reaction time (RT) to each stimulus,
using a microphone headset to detect verbal responses. A
button-box activated by the investigator was used to record
the response made (i.e. the colour name). This was designed
to allow the collection of performance data during the scan,
which had not been a feature of earlier studies [26]. The
number of correct and incorrect responses in each condition
and the mean RT for each condition were automatically
calculated. For each of the sets of trials, two average RTs
were computed. The Stroop effect was calculated as Stroop
RT minus Control RT; the NP effect was the NP RT minus
the Stroop RT. Calculation of the Stroop effect controls for
individual differences in speed of speech production,
important in ALS, and therefore represents a relatively pure
index of the degree of Stroop interference experienced (i.e.
the difficulty in inhibiting word reading so that the ink
colour can be named). The NP effect calculation also con-
trols for speed of speech production but, additionally,
controls for the passive cognitive inhibitory processes
involved in Stroop interference so that the NP effect then
represents a purer measure of the more active cognitive
inhibitory processes thought to be involved in the inhibition
of a previously primed stimulus. As a further means of
controlling for motor speech differences or more general
slowing, the Stroop RTs were also expressed as a percent-
age of the Control RTs, and the NP RTs were similarly
expressed as a percentage of the Stroop RT values.
Image acquisition
Functional MRI data were acquired on a GE Signa NV/i 1.5-T
MRI scanner (General Electric, Milwaukee, WI). One hun-
dred T2*-weighted EPI volumes depicting BOLD (blood
oxygenation level dependent) contrast were acquired in each
of 16 non-contiguous near-axial planes parallel to the anterior
commissure-posterior commissure line (64 9 64 matrix,
slice thickness = 7 mm, slice gap = 0.7 mm, 3 9 3 9
7 mm voxel size, TE = 40 ms, TR = 4,000 ms, flip
angle = 90, number of signal averages = 1). A sparse pulse
sequence design was used; 1,400 ms of image acquisition was
followed by 2,600 ms of quietness during which no images
were acquired and the participant could speak the name of the
colour aloud without any scanner noise. During the same
session, a 43-slice, high-resolution inversion recovery echo
planar image of the whole brain was acquired in the AC-PC
plane (128 9 128 matrix, slice thickness = 3 mm, slice
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gap = 0.3 mm, voxel size = 1.5 9 1.5 9 3 mm, TE =
73 ms, TR = 16,000 ms, TI = 180 ms). Data acquisition
from patients and controls was interleaved to ensure that a
shift in scanner performance would not lead to spurious
results. Echo planar imaging data quality was assessed using
an automated analysis technique [41].
T2-weighted fast spin echo images were also acquired for
each participant from 60 contiguous 3-mm slices (256 9 256
matrix, slice thickness = 3 mm, slice gap = 0 mm, voxel
size = 0.9 9 0.9 9 3 mm, TE = 80 ms, TR = 3,000 ms,
echo train length = 8) and were reviewed by an experienced
neuroradiologist to exclude any participants demonstrating
abnormalities unrelated to ALS.
Image analysis
All fMRI data analysis was undertaken using locally
written software, which has been extensively validated
[42–45]. All of the analysis up to the group stage was made
blinded to the participant’s identity.
Prior to time-series analysis, data were corrected for the
effects of head motion in 3D as previously described [42].
The data were analysed using a general linear model in
which the task design was convolved with a mixture of two
one-parameter gamma variate functions (peak responses at
4 and 8 s) to account for haemodynamic delay and dis-
persion. The time series at each voxel was regressed on the
convolved design. The parameters obtained from the
regression were used to calculate a ‘‘goodness of fit’’ sta-
tistic [the ratio of the sum of squares of the model fit and
the residual sum of squares (SSQ ratio)] at every voxel.
The significance of the statistic was then assessed by a
data-driven permutation approach [43, 44].
Data for each individual were transformed into the
standard space of Talairach and Tournoux [45, 46]. Dif-
ferences in activation between groups were tested for sig-
nificance using an analysis of variance (ANOVA) at each
voxel in standard space [45]. The median value of the
goodness of fit statistic was calculated at every voxel in
standard space (medians were used to minimise outlier
effects). The significance of these median values was then
assessed using non-parametric, data-driven, non-permuta-
tion-based procedures[45] that were extended to the cluster
level [47] in order to produce group difference images.
Results
Participant characteristics
The demographic and clinical data for the participants are
presented in Table 1. This shows that the two groups were
well matched for age, gender, estimates of premorbid Full
Scale IQ and mood. Although there was a trend for the
ALS group to appear more depressed, once the item ‘‘I feel
as if I am slowed down’’, which may reflect disease-related
symptoms rather than depression, was removed from the
calculation, there was no between-group difference on the
HADS depression subscale. None of the participants were
found to have any abnormalities on the T2-weighted
structural images incompatible with a diagnosis of ALS.
Behavioural performance during the fMRI tasks
Table 2 illustrates the reaction time (RT) and error data for
the ALS and control participants for all conditions. Due to
technical failure, RTs and error responses could not be
recorded across all conditions for two of the ALS partici-
pants. The RTs for the ALS group for the individual
Control, Stroop and NP conditions were significantly
longer than for the controls, as expected for ALS patients.
These differences in motor aspects of responding were
controlled for in the calculation of the Stroop and NP
effects. Both groups showed RT evidence of a Stroop effect
(i.e. Stroop RT minus Control RT; Wilcoxon signed ranks,
Control group: Z = -2.24, p = 0.025; ALS group: Z =
-3.059, p = 0.002). However, neither group showed clear
behavioural evidence of the NP effect in terms of differ-
ential RTs (i.e. NP RT minus Stroop RT; Wilcoxon signed
ranks, Control group: Z = -1.332, p = 0.183; ALS group:
Z = -1.412, p = 0.158), although for both groups the
mean NP RTs were the longest of the three mean RT
values. There were no between-group differences on either
the mean Stroop RT expressed as a percentage of the
Control RT or the NP RT values expressed as a percentage
of the Stroop RT values (Table 2). Although the between-
group difference for the Stroop effect did not reach sta-
tistical significance at p \ 0.05 using non-parametric
analyses (Table 2), given the small sample sizes the dif-
ference between the groups’ Stroop effect was further
considered by examining the effect size [48] for the
between-group comparison. This permitted an estimation
of the standardised mean difference between the two
groups (i.e. the effect size). Standardised against the entire
sample’s RTs for the Control condition, the between-group
difference for the Stroop effect reflected a large effect size
of d = 0.809 [48]. This suggested that there was greater
interference in responding for the ALS group, but that the
lack of statistical significance was likely to be due to the
small sample size in the current study. The between-group
difference for the NP effect was also not significant,
although the NP for the ALS group appeared somewhat
shorter than for controls. The between-group difference,
standardised against the standard deviation of the entire
sample’s Stroop RTs, reflected a small effect size
(d = 0.183) so that the difference in RTs will again not
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have reached significance given the sample size. Although
the two groups did not differ in the number of errors made
during Control or Stroop trials, there was a trend for the
ALS group to make more response errors during the NP
trials than the healthy control group (Table 2).
fMRI analyses
Stroop effect (Stroop minus control condition)
Brain regions differentially activated in the ALS and
healthy control groups during the Stroop minus control
conditions are shown in Fig. 1, with details of the regions
presented in Table 3.
All brain regions demonstrating significant between-
group activation differences showed increased activation
in the ALS group relative to controls. These regions were
located almost entirely in the left hemisphere. The
largest clusters were located in the left middle temporal
gyrus (predominantly BA 20/21), left superior tempo-
ral gyrus (predominantly BA 22) and left anterior cingulate
gyrus (predominantly BA 32). In addition, significant
clusters were observed in the left fusiform and lingual gyri
(both BA 18), left medial frontal gyrus (predominantly BA
9) and left inferior parietal cortex (BA 39/40). Subcortical
activation differences were found in the hippocampus,
caudate nucleus and insula, all on the left, as well as the
cerebellum.
Table 1 Demographic and clinical characteristics of participants
ALS Controls Statistic
Age (years) 52.6 (11.6) 52.4 (7.2) Mann-Whitney U = 52.5, Z = -0.239, p = 0.811
Gender 9 M: 5F 6 M: 2F Fisher’s exact test p = 1.0
NART-estimated IQ 118.0 (12.6) 124.6 (2.7) Mann-Whitney, U = 38.0,
Z = -1.023, p = 0.306
HADS anxiety (max 21) 7.1 (5.1) 5.8 (2.3) Mann-Whitney U = 47.0,
Z = 0.620, p = 0.536
HADS depression (max 21) 4.7 (3.1) 2.5 (2.9) Mann-Whitney U = 31.5,
Z = -1.685, p = 0.092
HADS depression (modified)* (max 18) 2.7 (2.7) 1.8 (2.0) Mann-Whitney U = 43.0,
Z = -0.909, p = 0.363
ALSSS N/A N/A
Bulbar (max 20) 16.5 (4.2) Range 8–20
Spinal (max 20) 14.9 (3.9) Range 8–19
Total (max 40) 32.1 (4.9) Range 23–39
All values mean (SD)
NART National Adult Reading Test, HADS Hospital Anxiety and Depression Scale, ALSSS ALS Severity Scale
* Item ‘‘I feel as if I am slowed down’’ removed
Table 2 Reaction times and error scores for scanning conditions and the overall Stroop and negative priming effects
ALS Controls Statistic
Control condition RT (ms) 802 (190) 641 (149) Mann-Whitney U = 18.5, Z = -2.277, p = 0.023
Stroop condition RT(ms) 932 (207) 717 (146) Mann-Whitney U = 13.0, Z = -2.70 p = 0.007
Negative priming condition RT (ms) 951 (179) 747 (134) Mann-Whitney U = 10.0, Z = -2.932, p = 0.003
Stroop effect RT (ms) 129 (60) 76 (65) Mann-Whitney U = 27.0, Z = -1.62 p = 0.105
Negative priming effect RT (ms) 20 (53) 29 (53) Mann-Whitney U = 46.0, Z = -0.154 p = 0.877
Stroop RT expressed as percentage of control RT 117 (8) 113 (12) Mann-Whitney U = 40.0, Z = -0.617, p = 0.537
NP RT expressed as percentage of Stroop RT 105 (9) 103 (6) Mann-Whitney U = 45.0, Z = -0.231, p = 0.817
Errors during control condition 0.4 (1.3) 0 (0) Mann-Whitney U = 44.0, Z = -0.816 p = 0.414
Errors during Stroop condition 0.3 (0.6) 0.1 (0.2) Mann-Whitney U = 41.5, Z = -0.720 p = 0.472
Errors during negative priming condition 0.6 (1.6) 0 (0) Mann-Whitney U = 32.0, Z = -1.767 p = 0.077
All values mean (SD)
2190 J Neurol (2011) 258:2186–2198
123
Negative priming effect (NP minus Stroop condition)
Brain regions differentially activated in the ALS and
healthy control groups during the NP minus Stroop con-
ditions are shown in Fig. 2, with details of the regions
presented in Table 4.
For this comparison, all regions showing significant
difference indicated reduced activation in the ALS group
compared to controls; these regions were predominantly in
the left hemisphere.
The largest cluster of reduced activation in the ALS
group was located in the left cingulate gyrus (predomi-
nantly BA 23/24). Smaller regions of differentially lower
activation in the ALS group were detected in the left pre-
central gyrus (BA 4/6) and left medial frontal gyrus (BA 6).
Lower levels of differential activation were found in
clusters involving the brainstem and the lingual and fusi-
form gyrus. Differences in cerebellar activation were also
observed (Fig. 2).
Discussion
Our findings demonstrate that, despite not achieving statis-
tically significant between-group differences in behavioural
measures during fMRI scanning, the ALS group showed
altered patterns of brain activation in comparisons designed
to elicit the Stroop effect and also the NP effect, when
compared to healthy controls.
Stroop effect
Both groups’ RT data indicated that they demonstrated the
presence of a Stroop effect. Although the RT differences
and numbers of errors made during the control and Stroop
tasks failed to detect statistically significant differences
between the ALS and control groups, we nonetheless found
a large effect size (d = 0.809) for the Stroop effect. The
direction of this difference suggested that the ALS group
was more susceptible to the interference between the
Fig. 1 Brain regions differentially activated in the ALS and healthy
control groups during the Stroop minus Control conditions (i.e. the
Stroop effect) at p = 0.001. All regions demonstrating significant
between-group activation differences (shown in red) showed
increased activation in the ALS group relative to healthy controls.
No areas of decreased activation in the ALS group relative to controls
were observed
J Neurol (2011) 258:2186–2198 2191
123
Table 3 Regions of significant difference (at p = 0.001) in activation for the Stroop effect (i.e. Stroop minus control condition) between ALS
patients and healthy controls
Cerebral region Brodmann area(s) Side Coordinates of centroid point Area (voxels)
X Y Z
ALS [ CON
Hippocampus – L -29 -9 -20 13
L -39 -19 -16 124
Inferior temporal gyrus 20, 37 L -51 -14 -20 17
L -60 -49 -12 7
Parahippocampal gyrus 19, 28, 36 L -34 -26 -20 30
L -40 -43 -8 26
L -38 -44 -4 4
Fusiform gyrus 18, 37 L -43 -52 -16 8
L -8 -85 -16 117
L -27 -96 -16 20
Middle temporal gyrus 20, 21, 39 L -49 -28 -12 98
L -55 -33 -8 110
L -51 -21 -4 7
L -58 -30 -4 13
L -53 -47 8 20
L -40 -67 20 71
Lingual gyrus 18 L -16 -84 -8 116
L -11 -74 -8 14
L -14 -89 -8 56
Superior temporal gyrus 21, 22, 42 L -51 -20 1 10
L -51 -20 4 10
L -56 -44 12 19
L -47 -53 12 25
L -48 -47 16 219
L -49 -36 20 124
Cingulate gyrus 24, 32 L -3 35 12 6
L -12 42 16 4
L -12 34 20 15
L -22 24 20 15
L -9 36 24 24
L -23 23 24 4
L -8 11 28 13
L -10 26 32 117
24, 32 R 1 34 16 5
R 2 35 20 4
Insula – L -35 24 12 37
Trans temporal gyrus 41 L -50 -19 12 13
Middle occipital gyrus 19 L -45 -71 12 8
Caudate nucleus – L -25 26 16 109
Medial frontal gyrus 9 R 3 38 24 3
R 3 38 28 4
9, 32 L -9 35 28 33
L -10 25 35 111
Postcentral gyrus 2 L -57 -16 24 3
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Fig. 2 Brain regions differentially activated in the ALS and healthy
control groups during the negative priming minus Stroop conditions
(negative priming effect) at p = 0.001. All regions demonstrating
significant between-group activation (shown in blue) showed
decreased activation in the ALS group relative to healthy controls.
No areas of increased activation in the ALS group relative to controls
were observed
Table 3 continued
Cerebral region Brodmann area(s) Side Coordinates of centroid point Area (voxels)
X Y Z
Inferior parietal 39, 40 L -48 -43 24 56
L -48 -62 24 7
L -41 -40 40 73
L -49 -36 45 26
L -35 -44 45 19
Superior occipital gyrus 19 L -36 -73 24 60
L -37 -73 28 59
L -38 -72 32 22
Supramarginal gyrus 40 L -53 -38 28 23
L -38 -46 28 13
L -55 -39 32 3
L -35 -43 32 14
L -38 -41 35 63
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colour words and inks, but that our findings were likely to
have been affected by the small sample size.
The ALS group showed increased activation in regions
associated with word representation (left superior temporal
gyrus; BA 22) and spatial attention (left inferior parietal
cortex BA 39/40). The latter differences may represent
covert shifts in attention between stimuli and response
requirements [26]. In addition, the large region of relatively
increased activation in the anterior cingulate (BA 24/32) is
not dissimilar from a cluster of relatively decreased
Table 4 Regions of significant difference (at p = 0.001) in activation for the negative priming effect (i.e. negative priming minus Stroop
condition) between ALS patients and healthy controls
Cerebral region Brodmann area(s) Side Coordinates of centroid point Area (voxels)
X Y Z
CON [ ALS
Brain stem – L -12 -39 -40 4
L -12 -39 -36 5
R 17 -38 -36 8
R 14 -39 -32 13
Fusiform gyrus 18 R 12 -90 -16 78
Lingual gyrus 17, 18 R 11 -89 -12 4
R 2 -85 -8 35
L -6 -75 -1 5
Cuneus 17 R 5 -89 -4 17
Precentral gyrus 4, 6 L -51 5 12 33
L -48 5 16 12
L -40 -11 20 164
L -44 -4 32 16
L -25 -23 45 4
L -26 -21 50 7
L -39 -27 50 6
L -37 -28 55 10
L -28 -23 60 38
Putamen – L -27 -4 16 20
Superior temporal gyrus 42 L -53 -27 16 6
Cingulate gyrus 23, 24, 29, L -28 -32 20 3
31 L -24 -28 24 33
L -29 -14 28 174
L -21 -19 32 107
L -20 -6 35 43
L -21 -28 35 42
L -12 0 40 116
L -26 -26 40 21
L -14 -28 40 27
L -14 -6 45 113
L -3 0 45 8
Postcentral gyrus 3 L -40 -11 24 177
Inferior parietal 40 L -54 -27 28 30
L -55 -28 35 3
Supramarginal gyrus 40 L -55 -29 35 11
Medial frontal gyrus 6 L -13 4 50 30
L -1 3 50 14
L -15 -4 55 122
L -10 -5 60 23
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activation observed in healthy control participants [31].
Steel et al.’s [26] main area of activation when comparing
the Stroop and control conditions was the cingulate gyrus,
and the current findings lend support to the validity of the
current scanning paradigm, as does the involvement of
other regions also previously found to be implicated in the
Stroop effect [26]. Previous findings in healthy controls of
parrahippocampal gyrus and cerebellar activation [26]
during the Stroop effect mirror areas differentiating
between the ALS and control groups in the current study,
although between-group differences in hippocampal acti-
vation were also seen in the present study. Whether this
reflects greater difficulty on the part of the ALS in
remembering on a trial-by-trial basis to name the ink rather
than reading the word cannot be determined from the
response data, but may be one factor underlying the
somewhat greater Stroop effect for the ALS group com-
pared to controls. Cerebellar activation during the Stroop
task has been reported in other patient groups (e.g. [49]).
As with their findings [49], the increased activation of the
cerebellum during the Stroop effect comparison may reflect
the maintained difficulty of the task for the ALS group such
that the task failed to become automatic for them. The RT
findings suggest that the ALS patients found the inhibitory
task more difficult than controls, resulting in greater acti-
vation of implicated brain regions. Further substantial
regions of increased cortical activation were observed in
the left middle temporal gyrus (BA 20/21) and the left
fusiform and lingual gyri (BA 17, 18; reported also by Steel
et al. [26]). Both the middle temporal gyrus [50] and the
lingual-fusiform border [32] have been implicated in the
processing of words or non-words rather than strings of
consonants. Thus the areas of increased activation might
suggest that the ALS patients had greater difficulty in
suppressing word reading in order to name the colour inks.
Negative priming effect
Behavioural data during scanning did not unequivocally
support our previous finding [6] that the ALS patients
might show reduced inhibitory processing in the compari-
son between the NP and Stroop tests. Although there was a
tendency for the ALS group to make more errors than
healthy controls during the NP trials, neither group showed
statistically different RTs in the comparison between the
NP and Stroop conditions. However both groups did show
their longest mean RTs in the NP condition, providing
some validity for the paradigm. The reason for the failure
to demonstrate a statistically significant NP effect (in terms
of RT measures) in either group is unclear, but both
groups’ RTs showed considerable variability in the extent
of their NP effect (Table 2). Our sample was older than
those reported in other imaging studies of NP [26, 30], and
varying findings have been reported concerning whether
increasing age reduces the magnitude of the NP effect [51].
In addition the need for a long response time, the periodic
block scanning design and the resulting short blocks of NP
trials may have provided insufficient opportunity for the
NP trials to have become sufficiently differentiated from
the Stroop trials in terms of their processing demands.
Nonetheless, our imaging findings suggest differential
patterns of stimulus processing by the two groups within
the NP effect scanning comparison. However, our follow-
ing interpretation of these findings can only be speculative
at this stage, given our small sample size.
In healthy controls, greater activation of specific brain
regions during NP trials relative to Stroop trials has been
reported [26], indicating the additional cognitive load
imposed by responding to a previously cognitively inhi-
bited stimulus. In the current study, relatively large clusters
reflecting reduced cerebral activation in the ALS group
compared to controls were found in two areas previously
associated with performance on this task: the left precentral
gyrus (BA 4/6) and left medial frontal gyrus (BA 6). It has
been suggested [26] that the precentral gyrus may con-
tribute to the processes of articulation of the target colour
at a specific trial; reduced activation in this region in the
ALS group might reflect higher levels of residual activation
of this target as a result of poorer suppression of the same
word when it appeared as a distractor in the previous trial.
The medial frontal cortex is likely to contribute to the
working memory or executive demands of the task (e.g.
internal representations of previous stimuli, self monitoring
of responses and the inhibition of unwanted responses).
The relatively reduced activation in this region in the ALS
group may reflect less effective cognitive inhibition of the
colour name in previous trials and therefore a reduced
demand for executive processes on current trials. Rela-
tively reduced cerebral activation in the left anterior and
posterior cingulate gyrus (BA 23/24) in the ALS group was
not consistent with findings in studies of NP in healthy
controls [26] where no differential activation of these areas
was reported. However, the reduced activation of these
regions in the ALS patients suggests that the cognitive
response inhibition and attentional demands of this test
may be processed differently by the ALS and control
participants. It also suggests that reactivation of the pre-
viously suppressed stimulus is less difficult for the ALS
group, due to previously less efficient response inhibition
processes. While clear involvement of medial temporal
regions in the NP effect has been reported [26], this was not
a substantial region showing differential activation
between the ALS and control groups, suggesting that the
ALS group did not differ substantially from controls in
their processing of the episodic retrieval component of the
NP task. Overall, the finding of relatively lower activation
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in the ALS group in the prefrontal regions associated with
the working memory and articulatory elements of NP
performance suggests that reactivation of the previously
suppressed stimulus was less difficult for the ALS group.
The finding of bilateral cerebellar activation, here found to
be reduced in the ALS group, was not consistent with
earlier studies in controls [26]. The finding of predomi-
nantly left-sided differences between the Control and ALS
groups’ pattern of activation would support findings of left
frontal lobe involvement in the active inhibitory processes
that contribute to NP [52].
Limitations of the present study
Although a strength of the present study was the collection
of online behavioural measures, the sample sizes for our
groups restricted the power available to detect between-
group differences on our behavioural measures. Power was
further reduced by the failure to record behavioural mea-
sures for two ALS participants. Our study is therefore very
much a pilot that needs future replication in a larger cohort.
Despite the collection of measures of premorbid IQ and
mood, further clarification of the extent of cognitive
impairment in the ALS group from neuropsychological
assessment was not available. The identification of more
generalised executive dysfunction and its relationship to
imaging findings in the present samples would have been
informative, especially in light of the heterogeneity of
cognitive involvement in ALS [3, 53]. In addition, our
scanning study design required the exclusion of ALS
patients with very marked speech impairments (i.e. more
severe bulbar impairment), and since this may have exclu-
ded patients with more pronounced cognitive impairment
[6], this may have influenced our findings.
Within our imaging paradigm, the sparse sequence
design and the need to accommodate for patients’ dysar-
thria resulted in longer ISIs (verbal response time) than
have been used in other studies (e.g. 2,600 ms used here as
compared to 1,900 ms elsewhere [26]). Although this will
not have influenced between-condition comparisons, this
does limit comparability with other studies of Stroop and
NP effects, and may explain some of the observed differ-
ences in regional activation between this and other studies.
In particular, it has been suggested that longer ISIs in the
Stroop task lead to more ‘routine’ performance of the task,
and it has been argued that attentional demands are reduced
under such conditions, leading to reduced prefrontal acti-
vation [54]. In addition different cortical circuits may be
activated at different stages of the Stroop response, with
frontocentral regions being implicated earlier in the process
than temporo-parietal regions [55], and our design may
have led to less frontal activation being detected. Future
studies might also usefully consider the relationship
between alterations in cortical inhibitory processes in ALS
(e.g. [56, 57]) and performance on measures of cognitive
inhibition.
These limitations notwithstanding, our findings demon-
strate the presence of greater cerebral activation in the ALS
group in the Stroop effect, reflecting apparently greater
difficulty in achieving response suppression. Findings of
areas of relatively lower cerebral activation in the ALS
group in the NP effect might support a model of stimulus
processing in the ALS group where lower levels of cog-
nitive inhibitory processes are employed, despite an
absence of an unequivocal between-group difference in
behavioural measures of the NP effect. These findings
extend the neuroimaging correlates of cognitive impair-
ment in patients with ALS [58] and suggest, as in other
studies [8], that functional imaging may detect evidence of
altered cerebral processing in ALS in the absence of
marked apparent cognitive dysfunction.
Acknowledgments We confirm that we have read the journal’s
position on issues involved in ethical publication and affirm that this
report is consistent with those guidelines. I N-D and VB were in
receipt of funding from the Medical Research Council, UK. The
King’s MND Care & Research Centre receives funding from the
Motor Neurone Disease Association UK. AS and PNL were in receipt
of funding from the Biomedical Research Centre for Mental Health at
South London and Maudsley NHS Foundation Trust and King’s
College London, Institute of Psychiatry.
Conflict of interest The authors have no conflict of interest to
declare.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Phukan J, Pender NP, Hardiman O (2007) Cognitive impairment
in amyotrophic lateral sclerosis. Lancet Neurology 6:994–1003
2. Raaphorst J, De Visser M, Linssen WHJP, De Haan RJ, Schmand
B (2010) The cognitive profile of amyotrophic lateral sclerosis: a
meta-analysis. Amyotroph Lateral Scler 11:27–37
3. Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM,
Schulz PE (2005) Prevalence and patterns of cognitive impair-
ment in sporadic ALS. Neurology 65:586–590
4. Strong MJ (2008) The syndromes of frontotemporal dysfunction
in amyotrophic lateral sclerosis. Amyotroph Lateral Scler
9:323–338
5. Goldstein LH (2006) Control of symptoms: cognitive dysfunc-
tion. In: Oliver D, Borasio GD, Walsh D (eds) Palliative care in
amyotrophic lateral sclerosis. Oxford University Press, Oxford,
pp 111–127
6. Abrahams S, Goldstein LH, Al Chalabi A et al (1997) Relation
between cognitive dysfunction and pseudobulbar palsy in
amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry
62:464–472
2196 J Neurol (2011) 258:2186–2198
123
7. Abrahams S, Goldstein LH, Lloyd CM, Brooks DJ, Leigh PN
(1995) Cognitive deficits in non-demented amyotrophic lateral
sclerosis patients: a neuropsychological investigation. J Neurol
Sci 129(Suppl):54–55
8. Abrahams S, Goldstein LH, Simmons A et al (2004) Word
retrieval in amyotrophic lateral sclerosis: a functional magnetic
resonance imaging study. Brain 127:1507–1517
9. Abrahams S, Leigh PN, Goldstein LH (2005) Cognitive change in
ALS: a prospective study. Neurology 64:1222–1226
10. Abrahams S, Leigh PN, Harvey A, Vythelingum GN, Grise D,
Goldstein LH (2000) Verbal fluency and executive dysfunction in
amyotrophic lateral sclerosis (ALS). Neuropsychologia 38:734–747
11. Kew JJ, Goldstein LH, Leigh PN et al (1993) The relationship
between abnormalities of cognitive function and cerebral acti-
vation in amyotrophic lateral sclerosis. A neuropsychological and
positron emission tomography study. Brain 116:1399–1423
12. Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK,
Miller B (2003) Are amyotrophic lateral sclerosis patients cog-
nitively normal? Neurology 60:1094–1097
13. Flaherty-Craig C, Brothers A, Dearman B, Eslinger P, Simmons
Z (2009) Penn state screen exam for the detection of frontal and
temporal dysfunction syndromes: application to ALS. Amyotroph
Lateral Scler 10:107–112
14. Abrahams S, Goldstein LH, Kew JJ, Brooks DJ, Lloyd CM, Frith
CD, Leigh PN (1996) Frontal lobe dysfunction in amyotrophic
lateral sclerosis. A PET study. Brain 119:2105–2120
15. Abrahams S, Leigh PN, Kew JJ, Goldstein LH, Lloyd CM,
Brooks DJ (1995) A positron emission tomography study of
frontal lobe function (verbal fluency) in amyotrophic lateral
sclerosis. J Neurol Sci 129(Suppl):44–46
16. Wicks P, Turner MR, Abrahams S, Hammers A, Brooks DJ,
Leigh PN, Goldstein LH (2008) Neuronal loss associated with
cognitive performance in amyotrophic lateral sclerosis: an (11C)-
flumazenil PET study. Amyotroph Lateral Scler 9:43–49
17. Abrahams S, Goldstein LH, Suckling J et al (2005) Frontotem-
poral white matter changes in amyotrophic lateral sclerosis.
J Neurology 253:321–331
18. Lule D, Ludolph AC, Kassubek J (2009) MRI-based functional
neuroimaging in ALS: an update. Amyotrophic Lateral Sclerosis
10:258–268
19. Chari G, Shaw PJ, Sahgal A (1996) Nonverbal visual attention,
but not recognition memory or learning processes are impaired in
motor neurone disease. Neuropsychologia 34:377–385
20. Frank B, Haas J, Heinze HJ, Stark E, Munte TF (1997) Relation
of neuropsychological and magnetic resonance findings in
amyotrophic lateral sclerosis: evidence for subgroups. Clin
Neurol Neurosurg 99:79–86
21. Hanagasi HA, Gurvit IH, Ermutlu N et al (2002) Cognitive
impairment in amyotrophic lateral sclerosis: evidence from neu-
ropsychological investigation and event-related potentials. Cogn
Brain Res 14:234–244
22. Ludolph AC, Langen KJ, Regard M et al (1992) Frontal lobe
function in amyotrophic lateral sclerosis: a neuropsychologic and
positron emission tomography study. Acta Neurol Scand
85:81–89
23. Pinkhardt EH, Jurgens R, Becker W et al (2008) Signs of
impaired selective attention in patients with amyotrophic lateral
sclerosis. J Neurol 255:532–538
24. Stroop J (1935) Studies of interference in serial verbal reactions.
Q J Exp Psychol 18:643–661
25. Tipper SP, Cranston M (1985) Selective attention and priming:
inhibitory and facilitatory effects of ignored primes. Q J Exp
Psychol A Hum Exp Psychol 37:591–611
26. Steel C, Haworth EJ, Peters E et al (2001) Neuroimaging corre-
lates of negative priming. NeuroReport 12:3619–3624
27. Egner T, Hirsch J (2005) Where memory meets attention: neural
substrates of negative priming. J Cogn Neurosci 17:1774–1784
28. Metzler C, Parkin AJ (2000) Reversed negative priming follow-
ing frontal lobe lesions. Neuropsychologia 38:363–379
29. Peters ER, Pickering AD, Hemsley DR (1994) ‘Cognitive inhi-
bition’ and positive symptomatology in schizotypy. Br J Clin
Psychol 33:33–48
30. Ungar L, Nestor PG, Niznikiewicz MA, Wible CG, Kubicki M
(2010) Color Stroop and negative priming in schizophrenia: an
fMRI study. Psychiat Res Neuroimaging 181:24–29
31. Leung H-C, Skudlarski P, Gatenby JC, Peterson BS, Gore JC
(2000) An event-related functional MRI study of the Stroop color
word interference task. Cereb Cortex 10:552–560
32. Peterson BS, Skudlarski P, Gatenby JC, Zhang H, Anderson AW,
Gore JC (1999) An fMRI study of Stroop word-color interfer-
ence: evidence for cingulate subregions subserving multiple
distributed attentional systems. Biol Psychiatry 45:1237–1258
33. Maekawa S, Al Sarraj S, Kibble M et al (2004) Cortical selective
vulnerability in motor neuron disease: a morphometric study.
Brain 127:1237–1251
34. Stanton BR, Williams VC, Leigh PN et al (2007) Altered cortical
activation during a motor task in ALS: evidence for involvement
of central pathways. J Neurol 254:1260–1267
35. Brooks BR, Miller RG, Swash M, Munsat TL, World Federation
of Neurology Research Group on Motor Neuron Diseases (2000)
El Escorial revisited: revised criteria for the diagnosis of amyo-
trophic lateral sclerosis. Amyotroph Lateral Scler Other Motor
Neuron Dis 1:293–299
36. Mustfa N, Walsh E, Bryant V et al (2006) The effect of nonin-
vasive ventilation on ALS patients and their caregivers. Neurol-
ogy 66:1211–1217
37. Newsom-Davis IC, Lyall RA, Leigh PN, Moxham J, Goldstein
LH (2001) The effect of non-invasive positive pressure ventila-
tion (NIPPV) on cognitive function in amyotrophic lateral scle-
rosis (ALS): a prospective study. J Neurol Neurosurg Psychiatry
71:482–487
38. Hillel AD, Miller RM, Yorkston K, McDonald E, Norris FH,
Konikow N (1989) Amyotrophic lateral sclerosis severity scale.
Neuroepidemiology 8:142–150
39. Nelson HE, Willison J (1991) National Adult Reading Test
(NART) second edition. NFER-Nelson, Windsor
40. Zigmond AS, Snaith RP (1983) The hospital anxiety and
depression scale. Acta Psychiat Scand 67:361–370
41. Simmons A, Moore E, Williams SCR (1999) Quality control for
functional magnetic resonance imaging using automated data
analysis and Shewhart charting. Magn Res Med 41:1274–1278
42. Bullmore ET, Brammer MJ, Rabe-Hesketh S et al (1999) Meth-
ods for diagnosis and treatment of stimulus-correlated motion in
generic brain activation studies using fMRI. Hum Brain
Map 7:38–48
43. Bullmore E, Brammer M, Williams SCR et al (1996) Statistical
methods of estimation and inference for functional MR image
analysis. Magn Reson Med 35:261–277
44. Bullmore ET, Long C, Suckling J et al (2001) Colored noise and
computational inference in neurophysiological (fMRI) time series
analysis: resampling methods in time and wavelet domains. Hum
Brain Mapp 12:61–78
45. Brammer MJ, Bullmore ET, Simmons A et al (1997) Generic
brain activation mapping in functional magnetic resonance
imaging: a nonparametric approach. Magn Res Imaging
15:763–770
46. Talairach J, Tournoux P (1988) CoPlanar sterotaxic atlas of the
human brain. Thieme, Stuttgart
47. Bullmore ET, Suckling J, Overmeyer S, Rabe-Hesketh S, Taylor
E, Brammer MJ (1999) Global, voxel, and cluster tests, by theory
J Neurol (2011) 258:2186–2198 2197
123
and permutation, for a difference between two groups of struc-
tural MR images of the brain. IEEE Transact Med Imag 18:32–42
48. Cohen JA (1992) A power primer. Psychol Bull 112:155–159
49. Rocca MA, Valsasina P, Ceccarelli A et al (2009) Structural and
functional MRI correlates of Stroop control in benign MS. Hum
Brain Mapp 30:276–290
50. Price CJ, Wise RJS, Watson JDG, Patterson K, Howard D,
Frackowiak RSJ (1994) Brain activity during reading. The effects
of exposure duration and task. Brain 117:1255–1269
51. Gamboz N, Russo R, Fox E (2002) Age differences and the
identity negative priming effect: an updated meta-analysis. Psy-
chol Aging 17:525–531
52. McDonald CR, Bauer RM, Filoteo JV, Grande L, Roper SN,
Gilmore R (2005) Attentional inhibition in patients with focal
frontal lobe lesions. J Clin Exp Neuropsychol 27:485–503
53. Wicks P, Abrahams S, Papps B, Leigh PN, Goldstein LH (2009)
SOD1 and cognitive dysfunction in familial amyotrophic lateral
sclerosis. J Neurol 256:234–241
54. Bench C, Frith CD, Grasby PM et al (1993) Investigations of the
functional anatomy of attention using the Stroop test. Neuro-
psychologia 31:907–922
55. Xiao X, Qiu J, Zhang Q (2009) The dissociation of neural circuits
in a Stroop task. NeuroReport 20:674–678
56. Turner MR, Osei-Lah AD, Hammers A et al (2005) Abnormal
cortical excitability in sporadic but not homozygous D90A SOD1
ALS. J Neurol Neurosurg Psychiatry 76:1279–1285
57. Steve V, Kiernan MC (2009) Abnormalities of intracortical
pathways in amyotrophic lateral sclerosis—developing new
therapeutic targets. J Clin Neurosci Conf Proc 1516–1517
58. Tsermentseli S, Goldstein LH, Leigh PN (2011) The anatomy of
cognitive impairment in amyotrophic lateral sclerosis: more than
frontal lobe dysfunction. Cortex. doi:10.1016/j/cortex.2011.
02.004
2198 J Neurol (2011) 258:2186–2198
123
